(R)-Butaprost is primarily used in medical research as a selective agonist for the prostaglandin EP2 receptor. It plays a significant role in studying the physiological and pathological processes mediated by this receptor, particularly in inflammation, pain, and immune responses. Researchers utilize (R)-Butaprost to investigate its effects on smooth muscle relaxation, making it valuable in understanding conditions like asthma and cardiovascular diseases. Additionally, it is employed in studies related to bone metabolism and wound healing, as EP2 receptor activation has been linked to these processes. Its application in experimental models helps in developing potential therapeutic strategies for various diseases.